跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Atectura Breezhaler 125 micrograms/127.5 micrograms inhalation powder (hard capsules) - UK EMC Drug Approval Details
Approvals
/
UK EMC
/
Atectura Breezhaler 125 micrograms/127.5 micrograms inhalation powder (hard capsules)
Approved
STANDARD
Atectura Breezhaler 125 micrograms/127.5 micrograms inhalation powder (hard capsules)
Novartis Pharmaceuticals UK Ltd
🇬🇧 Electronic Medicines Compendium
Approval Date
N/A
Approval ID
74026a089afba247
Company
Novartis Pharmaceuticals UK Ltd
Type
Standard
Approval Details
Approval Id
74026a089afba247
Drug Approval Emc Name
Atectura Breezhaler 125 micrograms/127.5 micrograms inhalation powder (hard capsules)
Drug Name
Atectura Breezhaler 125 micrograms/127.5 micrograms inhalation powder (hard capsules)
Company Name
Novartis Pharmaceuticals UK Ltd
Company Address
2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ
Company Telephone
+44 (0)1276 692 255
Company Medical Info Direct Line
+44 (0)1276 698 370
Company Medical Info Email
medinfo.uk@novartis.com
Company Customer Care Direct Line
+44 (0)845 741 9442
Atc Code
R03AK14
Legal Category
Prescription only medicine
Active Ingredients
Approved
Quick Info
Agency
UK EMC
Country
🇬🇧
Approval ID
74026a089afba247
Type
Standard
Back to UK EMC Approvals